Biotech layoffs, slumping stocks, and a 2024 preview

What's the best JPM hangover cure? And what if the hangover is just Covid?

January 19, 2024 Check out STAT+

Sponsored By

Why are rich biotechs cutting costs? Has JPM Week already worn off? And what's going to move markets in 2024? We cover all that and more this week on "The Readout LOUD," STAT's biotech podcast. Our colleague Jason Mast joins us to discuss an emerging trend in biotech: Cash-rich startups are laying off employees and tweaking their strategies amid a tough market for venture capital. We also look ahead to the biggest biotech stories coming in 2024, including some major data readouts and a few pivotal FDA decisions. Listen Now Subscribe to the podcast to never miss an episode iTunes Google Spotify SoundCloud Podcast Addict TuneIn Visit the archive to see past episodes

---

---

Enjoying The Readout LOUD? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser